Stephen D. Nimer
Direktor/Vorstandsmitglied bei Bone Marrow & Cancer Foundation, Inc.
Aktive Positionen von Stephen D. Nimer
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Cornell University
Cornell University Other Consumer ServicesConsumer Services Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY. | Corporate Officer/Principal | 01.01.1993 | - |
Bone Marrow & Cancer Foundation, Inc.
Bone Marrow & Cancer Foundation, Inc. Miscellaneous Commercial ServicesCommercial Services The Bone Marrow Foundation is a non profit organization which offers financial assistance and free support services to bone marrow or stem cell transplant patients and their families. The company was founded by Christina Merrill in 1992 and is headquartered in New York, NY. | Direktor/Vorstandsmitglied | - | - |
Karriereverlauf von Stephen D. Nimer
Ehemalige bekannte Positionen von Stephen D. Nimer
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Abraxis BioScience, Inc.
Abraxis BioScience, Inc. Pharmaceuticals: MajorHealth Technology Abraxis Bioscience, Inc. develops therapeutics for cancer, infectious diseases and other critical illnesses. Its development platform uses nanoparticle albumin-bound technology to deliver drugs to tumors that produce SPARC. Abraxene, the first protein-based nanoparticle chemotherapeutic compound, is FDA approved for treating metastatic breast cancer. Abraxis Bioscience is focused on expanding the use of Abraxene and developing other drug candidates utilizing the same technology. Abraxene is approved for marketing in over 35 countris and the company has manufacturing facilities in the United States and Switzerland. Abraxis Bioscience was organized in 2007 from the oncology and research businesses of American Pharmaceutical Partners, Inc. and is headquartered in Los Angeles, CA. | Direktor/Vorstandsmitglied | 01.11.2007 | 30.03.2011 |
Abraxis BioScience, Inc. /Old/
Abraxis BioScience, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Abraxis BioScience, Inc. manufactures specialty pharmaceutical products. The company develops, manufactures and markets injectable products and leverages revolutionary technology such as its nab(TM) platform to discover and deliver breakthrough therapeutics that transform the treatment of cancer and other life threatening diseases. The company is located in Schaumburg, IL | Direktor/Vorstandsmitglied | 01.05.2001 | 13.11.2007 |
American Pharmaceutical Partners, Inc.
American Pharmaceutical Partners, Inc. Pharmaceuticals: MajorHealth Technology American Pharmaceutical Partners, Inc. is engaged in to developing, manufacturing and marketing injectable pharmaceutical products. The company produces generic injectable pharmaceutical products in more than 300 dosages and formulations. The company focuses mainly in the oncology, anti-infective and critical care markets. The company is located in Schaumburg, IL. | Direktor/Vorstandsmitglied | - | 20.04.2006 |
Ausbildung von Stephen D. Nimer
The University of Chicago | Doctorate Degree |
Massachusetts Institute of Technology | Undergraduate Degree |
Statistik
International
Vereinigte Staaten | 8 |
Operativ
Director/Board Member | 4 |
Corporate Officer/Principal | 1 |
Doctorate Degree | 1 |
Sektoral
Health Technology | 4 |
Consumer Services | 3 |
Finance | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 4 |
---|---|
American Pharmaceutical Partners, Inc.
American Pharmaceutical Partners, Inc. Pharmaceuticals: MajorHealth Technology American Pharmaceutical Partners, Inc. is engaged in to developing, manufacturing and marketing injectable pharmaceutical products. The company produces generic injectable pharmaceutical products in more than 300 dosages and formulations. The company focuses mainly in the oncology, anti-infective and critical care markets. The company is located in Schaumburg, IL. | Health Technology |
Abraxis BioScience, Inc. /Old/
Abraxis BioScience, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Abraxis BioScience, Inc. manufactures specialty pharmaceutical products. The company develops, manufactures and markets injectable products and leverages revolutionary technology such as its nab(TM) platform to discover and deliver breakthrough therapeutics that transform the treatment of cancer and other life threatening diseases. The company is located in Schaumburg, IL | Health Technology |
Abraxis BioScience, Inc.
Abraxis BioScience, Inc. Pharmaceuticals: MajorHealth Technology Abraxis Bioscience, Inc. develops therapeutics for cancer, infectious diseases and other critical illnesses. Its development platform uses nanoparticle albumin-bound technology to deliver drugs to tumors that produce SPARC. Abraxene, the first protein-based nanoparticle chemotherapeutic compound, is FDA approved for treating metastatic breast cancer. Abraxis Bioscience is focused on expanding the use of Abraxene and developing other drug candidates utilizing the same technology. Abraxene is approved for marketing in over 35 countris and the company has manufacturing facilities in the United States and Switzerland. Abraxis Bioscience was organized in 2007 from the oncology and research businesses of American Pharmaceutical Partners, Inc. and is headquartered in Los Angeles, CA. | Health Technology |
Bone Marrow & Cancer Foundation, Inc.
Bone Marrow & Cancer Foundation, Inc. Miscellaneous Commercial ServicesCommercial Services The Bone Marrow Foundation is a non profit organization which offers financial assistance and free support services to bone marrow or stem cell transplant patients and their families. The company was founded by Christina Merrill in 1992 and is headquartered in New York, NY. | Commercial Services |
- Börse
- Insiders
- Stephen D. Nimer
- Erfahrung